Pharmacokinetics of the ghrelin agonist capromorelin in a single ascending dose Phase-I safety trial in spinal cord-injured and able-bodied volunteers

Growth hormone (GH)-releasing hormone and GH secretagogues in normal aging: Fountain of Youth or Pool of Tantalus?

(2016) Everly Macario   Clinical Interventions in Aging

The mechanism of enhanced defecation caused by the ghrelin receptor agonist, ulimorelin

(2013) R. V. Pustovit et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Stimulation of defecation in spinal cord-injured rats by a centrally acting ghrelin receptor agonist

(2011) D M Ferens et al.   SPINAL CORD

Effects of an Oral Growth Hormone Secretagogue in Older Adults

(2009) Heidi K. White et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The need for manual evacuation and oral laxatives in the management of neurogenic bowel dysfunction after spinal cord injury: a randomized controlled trial of a stepwise protocol

(2009) M J Coggrave et al.   SPINAL CORD

Intramuscular Neostigmine and Glycopyrrolate Safely Accelerated Bowel Evacuation in Patients with Spinal Cord Injury and Defecatory Disorders

(2008) Alan S. Rosman et al.   DIGESTIVE DISEASES AND SCIENCES